Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-09
2011-08-09
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S523000, C549S305000, C549S306000
Reexamination Certificate
active
07994162
ABSTRACT:
The present invention relates to 2-alkoxy-3,4,5-trihydroxyalkylamide benzodiazepine compounds, to pharmaceutical compositions comprising such compounds, to methods of treatment comprising administering such compounds, to processes for the preparation of such compounds, and to intermediate precursors to such compounds.
REFERENCES:
patent: 4692522 (1987-09-01), Parsons et al.
patent: 4831135 (1989-05-01), Crews et al.
patent: 5283241 (1994-02-01), Bochis et al.
patent: 6239127 (2001-05-01), Kinder, Jr. et al.
patent: 7153846 (2006-12-01), Hoffmann et al.
patent: 7550453 (2009-06-01), Zhang et al.
patent: 2002/0128474 (2002-09-01), Xu et al.
patent: 2007/0065929 (2007-03-01), Hoffmann et al.
patent: 2007/0065932 (2007-03-01), Haag-Richter et al.
patent: 2007/0244087 (2007-10-01), Zhang et al.
patent: 2007/0249584 (2007-10-01), Zhang et al.
patent: 0 687 673 (1995-12-01), None
patent: 2004262793 (2004-09-01), None
patent: WO 98/35941 (1998-08-01), None
patent: WO 00/29382 (2000-05-01), None
patent: WO 01/85697 (2001-11-01), None
patent: WO 02/39990 (2002-05-01), None
patent: WO 2005/014574 (2005-02-01), None
patent: WO 2005/044803 (2005-05-01), None
patent: WO 2006/056696 (2006-06-01), None
U.S. Appl. No. 12/267,691, filed Nov. 10, 2008, Zhang et al.
U.S. Appl. No. 12/267,692, filed Nov. 10, 2008, Zhang et al.
Adamczeski et al, Novel Sponge-Derived Amino Acids. 5. Structures, Stereochemistry, and Synthesis of Several New Heterocycles, J. Am. Chem. Soc. 1989, 111, pp. 647-654.
Chang et al, Synthesis of optically active alpha-aminobenzolactam via an oxidative-cyclization reaction, Tetrahedron: Asymmetry 14 (2003) pp. 2081-2085.
Groweiss, et al., Cytotoxic Metabolites from an Australian Collection of the Sponge, J. Nat. Prod.; 1999; 62; pp. 1691-1693.
Kinder et al, Synthesis and Antitumor Activity of Ester-Modified Analogues of Bengamide B, J. Med. Chem. 2001, 44, pp. 3692-3699.
Morton et al, Novel Solid-Phase Sythesis of 1,5-benzothiazepine-4-one Derivatives, Tetrahedron Letters 41 (2000) pp. 3029-3033.
Parsons et al, Cholecystokinin Antagonists. Synthesis and Biological Evaluation of a 3-Substituted Benzolactams, J. Med. Chem. 1989, 32, pp. 1681-1685.
Quinoa et al, Bengamides, Heterocyclic Anthelminthics from a Jaspidae Marine Sponge, J. Org. Chem. (1986) 51, pp. 4494-4497.
Ramana et al, A Carbohydrate-Based Approach for the Total Synthesis of 1,3-Polyol/alpha-Pyrone Antifungal Natural Products, J. Org. Chem. 2005, 70, pp. 8216-8219.
Slade et al, Angiotensin Converting Enzyme Inhibitors: 1,5-Benzothiazepine Derivatives, J. Med. Chem., 1985, 28, pp. 1517-1521.
Thale et al, Bengamides Revisited: New Structures and Antitumor Studies, J. Org. Chem. 2001, 66, pp. 1733-1741.
Commerçon Alain
Nardi Frederico
Zhang Jidong
Kifle Bruck
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2715880